Ozawa K, Uemoto S, Tanaka K, Kumada K, Yamaoka Y, Kobayashi N, Inamoto T, Shimahara Y, Mori K, Honda K
Second Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Ann Surg. 1992 Nov;216(5):547-53. doi: 10.1097/00000658-199211000-00004.
The authors performed 20 liver transplantations from living related donors between June 1990 and July 1991. The 20 pediatric patients (14 biliary atresia, two Budd-Chiari syndrome, one liver cirrhosis after hepatitis C viral infection (HCV hepatitis), 1 progressive intrahepatic cholestasis, 1 liver cirrhosis, 1 protoporphyria) were transplanted with 11 left lobes, eight left lateral segments, and one right lobe. The choice of donors was restricted to the parents of the recipients. The immunosuppressive treatment consisted of FK 506 and steroids. Seventeen recipients are alive, 15 of whom are well and at home. Two recipients, who underwent emergency transplantation, died of postoperative complications. Another recipient died of accidental asphyxia at 6 months after the transplantation. All 20 donors had uneventful postoperative courses and were able to resume their normal social lives. The arterial ketone body ratio (AKBR) increased to above 1.0 within 2 days after the transplantation in all cases. Relatively mild rejection episodes were encountered in only two cases transplanted with ABO-compatible grafts, and these were treated successfully with steroids and FK 506.
1990年6月至1991年7月期间,作者进行了20例亲属活体供肝肝移植手术。20例儿科患者(14例胆道闭锁、2例布加综合征、1例丙型肝炎病毒感染(丙型肝炎)后肝硬化、1例进行性肝内胆汁淤积、1例肝硬化、1例原卟啉症)接受了移植,其中11例为左半肝、8例为左外叶、1例为右半肝。供体选择限于受者的父母。免疫抑制治疗包括使用FK 506和类固醇。17例受者存活,其中15例情况良好,已回家。2例接受急诊移植的受者死于术后并发症。另1例受者在移植后6个月死于意外窒息。所有20例供体术后过程顺利,能够恢复正常社会生活。所有病例移植后2天内动脉血酮体比率(AKBR)均升至1.0以上。仅2例接受ABO血型相容移植物移植的病例出现相对轻微的排斥反应,经类固醇和FK 506治疗成功。